Viewing data from:

CYCLOGYL

ANDA

CYCLOPENTOLATE HYDROCHLORIDE | A084108 | ALCON LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Cyclogyl (2023)

Total Spending

$27K

Total Claims

366

Beneficiaries

272

Avg Cost/Unit

$10.76

Spending Trend

$20K(2019)→$20K(2020)→$25K(2021)→$17K(2022)→$27K(2023)

YoY Change:+24.0%

5yr CAGR:+6.5%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain2 active DMFs1 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

ESTEVE QUIMICA SACYCLOPENTOLATE HYDROCHLORIDE

DMF 72721987

C-SQUARED PHARMA LTDCYCLOPENTOLATE HYDROCHLORIDE

DMF 363422021

PHARMECO LABORATORIES INCInactiveCYCLOPENTOLATE HYDROCHLORIDE (P-637)

DMF 67591986

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 2%

RLDAT

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.